Nerve growth factor inhibitor with novel-binding domain demonstrates nanomolar efficacy in both cell-based and cell-free assay systems.

Autor: Kennedy, Allison E.1,2, Laamanen, Corey A.1,3, Ross, Mitchell S.1, Vohra, Rahul1,4, Boreham, Douglas R.1, Scott, John A.1,3, Ross, Gregory M.1 gross@nosm.ca
Zdroj: Pharmacology Research & Perspectives. Oct2017, Vol. 5 Issue 5, pn/a-N.PAG. 15p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje